Epilepsy drugs could treat Alzheimer's and Parkinson's

Oct 27, 2009

Researchers in the USA have discovered a potential new function for anti-epileptic drugs in treating neurodegenerative disorders such as Alzheimer's and Parkinson's disease. The study, published in BioMed Central's open access journal Molecular Neurodegeneration, found that neurons in the brain were protected after treatment with T-type calcium-channel blockers, which are commonly used to treat epilepsy.

Calcium signaling pathways play a vital role in the survival of neurons in the brain. As age increases, calcium homeostasis can be disrupted in the brain, which may lead to cognitive and functional decline. It therefore raises the possibility that chemicals able to modulate calcium homeostasis could protect neurons.

Jianxin Bao and colleagues, from Washington University, Missouri, USA, were one of the first teams to explore the possible protective effects of blockers for T-type calcium channels. The mechanisms for neuroprotection by these antiepileptic drugs were previously unknown. Bao's team established cell culture models to directly test whether these drugs could preserve neurons in long- and short-term cultures in vitro.

They found that neurons showed an increase in viability after treatment with either L-type or T-type calcium channel inhibitors. Furthermore, neurons in the long-term and short-term cultures were protected, respectively, by L-type and T-type blockers, suggesting that more than one calcium-signaling mechanism exists to regulate long- and short-term neuron survival.

There are presently no effective medications for age-related neurodegeneration. Bao said "Our data provides implications for the use of this family of anti-epileptic drugs in developing new treatments for neuronal injury, and for the need of further studies of the use of such drugs in age-related neurodegenerative disorders."

More information: Neuroprotective effects of blockers for T-type calcium channels, Norelle C Wildburger, Avary Lin-Ye, Michelle A Baird, Debin Lei and Jianxin Bao, Molecular Neurodegeneration (in press), www.molecularneurodegeneration.com/

Source: BioMed Central (news : web)

Explore further: Cornell chemists show ALS is a protein aggregation disease

add to favorites email to friend print save as pdf

Related Stories

High blood pressure pill cuts risk of Parkinson's disease

Feb 06, 2008

People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson’s disease, according to a study published in the February 6, 2008, ...

Calcium may be the key to understanding Alzheimer's disease

Jul 18, 2008

Researchers at the University of Pennsylvania School of Medicine have shown that mutations in two proteins associated with familial Alzheimer's disease disrupt the flow of calcium ions within neurons. The two proteins, called ...

Calcium channels optimize learning

Sep 18, 2009

(PhysOrg.com) -- Researchers at the Friedrich Miescher Institute for Biomedical Research, Switzerland, have shown how calcium channels in the brain have a positive impact on learning. Their results have been ...

Tracing the formation of long-term memory

Dec 06, 2006

The formation of long-term memory in fruit flies can be demonstrated by the influx of calcium into cells called mushroom body neurons that occurs after special training that includes periods of rest, said researchers from ...

Researchers reveal mechanism for neuron self-preservation

Oct 19, 2009

Tsuruta et al. find that a lipid kinase directs a voltage-gated calcium channel's degradation to save neurons from a lethal dose of overexcitement. The study appears in the October 19, 2009 issue of the Journal of ...

Mechanism explains calcium abnormalities in Alzheimer's brain

Jun 25, 2008

A new study uncovers a mechanism that directly links mutations that cause early onset Alzheimer's disease (AD) with aberrant calcium signaling. The research, published by Cell Press in the June 26th issue of the journal Neuron, provid ...

Recommended for you

New ALS associated gene identified using innovative strategy

21 hours ago

Using an innovative exome sequencing strategy, a team of international scientists led by John Landers, PhD, at the University of Massachusetts Medical School has shown that TUBA4A, the gene encoding the Tubulin Alpha 4A protein, ...

Can bariatric surgery lead to severe headache?

21 hours ago

Bariatric surgery may be a risk factor for a condition that causes severe headaches, according to a study published in the October 22, 2014, online issue of Neurology, the medical journal of the American Academy of Neurol ...

Bipolar disorder discovery at the nano level

21 hours ago

A nano-sized discovery by Northwestern Medicine scientists helps explain how bipolar disorder affects the brain and could one day lead to new drug therapies to treat the mental illness.

User comments : 0